Karen Fitzner

1.0k total citations
36 papers, 749 citations indexed

About

Karen Fitzner is a scholar working on Economics and Econometrics, General Health Professions and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Karen Fitzner has authored 36 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Economics and Econometrics, 10 papers in General Health Professions and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Karen Fitzner's work include Diabetes Management and Education (9 papers), Diabetes Management and Research (9 papers) and Healthcare Policy and Management (9 papers). Karen Fitzner is often cited by papers focused on Diabetes Management and Education (9 papers), Diabetes Management and Research (9 papers) and Healthcare Policy and Management (9 papers). Karen Fitzner collaborates with scholars based in United States, Hong Kong and United Kingdom. Karen Fitzner's co-authors include Charles L. Bennett, Suzanne Austin Boren, Glen T. Schumock, Elizabeth A. Calhoun, Denise Finley, N. S. Gorby, Michael Wolf, Ian Duncan, Ahsan M. Arozullah and Barbara A. Stetson and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and Obesity.

In The Last Decade

Karen Fitzner

34 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Fitzner United States 14 280 265 196 179 144 36 749
Rahul Shenolikar United States 13 84 0.3× 125 0.5× 98 0.5× 87 0.5× 85 0.6× 47 531
Kathleen Lang United States 16 115 0.4× 43 0.2× 162 0.8× 83 0.5× 246 1.7× 33 764
David E. Milov United States 12 180 0.6× 46 0.2× 51 0.3× 104 0.6× 53 0.4× 27 660
Francisco Ortega Spain 16 63 0.2× 38 0.1× 114 0.6× 76 0.4× 67 0.5× 32 816
Bruno Rushforth United Kingdom 8 116 0.4× 138 0.5× 46 0.2× 176 1.0× 31 0.2× 22 459
Luke Mounce United Kingdom 16 250 0.9× 22 0.1× 86 0.4× 117 0.7× 193 1.3× 49 675
Reed Mszar United States 15 184 0.7× 76 0.3× 79 0.4× 94 0.5× 16 0.1× 50 693
Christelle Gastaldi‐Ménager France 10 76 0.3× 56 0.2× 70 0.4× 72 0.4× 30 0.2× 23 314
Allan Grill Canada 13 133 0.5× 70 0.3× 91 0.5× 144 0.8× 9 0.1× 33 569
Arnold Degboe United States 11 81 0.3× 81 0.3× 54 0.3× 77 0.4× 136 0.9× 31 600

Countries citing papers authored by Karen Fitzner

Since Specialization
Citations

This map shows the geographic impact of Karen Fitzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Fitzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Fitzner more than expected).

Fields of papers citing papers by Karen Fitzner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Fitzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Fitzner. The network helps show where Karen Fitzner may publish in the future.

Co-authorship network of co-authors of Karen Fitzner

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Fitzner. A scholar is included among the top collaborators of Karen Fitzner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Fitzner. Karen Fitzner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Duncan, Ian, et al.. (2021). Patient Post-discharge Transitions and Inpatient Readmissions Impose Costly Burdens for Employers and Carriers. Population Health Management. 24(6). 722–726. 2 indexed citations
3.
Fitzner, Karen, et al.. (2018). Impact of Cost on the Safety of Cancer Pharmaceuticals. Cancer treatment and research. 1–20. 4 indexed citations
4.
5.
Raizer, Jeffrey J., Karen Fitzner, Daniel I. Jacobs, et al.. (2015). Economics of Malignant Gliomas: A Critical Review. Journal of Oncology Practice. 11(1). e59–e65. 47 indexed citations
6.
Duncan, Ian, et al.. (2012). Effects of Cancer Comorbidity on Disease Management: Making the Case for Diabetes Education (A Report from the SOAR Program). Population Health Management. 16(1). 53–57. 18 indexed citations
7.
Fitzner, Karen, et al.. (2012). A Problem-Solving Approach to Effective Insulin Injection for Patients at Either End of the Body Mass Index. Population Health Management. 15(3). 168–173. 1 indexed citations
8.
Fitzner, Karen, et al.. (2008). An Assessment of Patient Education and Self-Management in Diabetes Disease Management—Two Case Studies. Population Health Management. 11(6). 329–340. 22 indexed citations
9.
Bennett, Charles L., Cara C. Tigue, & Karen Fitzner. (2007). The Economics of Brain Metastases. Cancer treatment and research. 136. 23–29. 3 indexed citations
10.
Sidorov, Jaan & Karen Fitzner. (2006). Obesity Disease Management Opportunities and Barriers. Obesity. 14(4). 645–649. 12 indexed citations
11.
Fitzner, Karen, et al.. (2006). Disease Management: A Mid-Decade Evolution Toward Patient Safety. Home Health Care Management & Practice. 18(3). 178–185. 3 indexed citations
12.
Calhoun, Elizabeth A., Glen T. Schumock, June M. McKoy, et al.. (2005). Granulocyte Colony-Stimulating Factor for Chemotherapy-Induced Neutropenia in Patients with Small Cell Lung Cancer. PharmacoEconomics. 23(8). 767–775. 15 indexed citations
13.
Friedman, Neal, et al.. (2005). Patient Satisfaction Measurement in the Disease Management Industry. Disease Management. 8(5). 288–300. 22 indexed citations
14.
Fitzner, Karen, Kathe Fox, Joseph D. Schmidt, et al.. (2005). Implementation and Outcomes of Commercial Disease Management Programs in the United States: The Disease Management Outcomes Consolidation Survey. Disease Management. 8(4). 253–264. 16 indexed citations
15.
Fitzner, Karen, Jaan Sidorov, Donald Fetterolf, et al.. (2004). Principles for Assessing Disease Management Outcomes. Disease Management. 7(3). 191–201. 29 indexed citations
16.
Fitzner, Karen, et al.. (2003). New Evidence to Explain Rising Healthcare Costs. The American Journal of Managed Care. 9(1). 3 indexed citations
17.
Fitzner, Karen, et al.. (2003). Are health plans changing their views on nutrition service coverage?. Journal of the American Dietetic Association. 103(2). 157–161. 6 indexed citations
18.
Fitzner, Karen, et al.. (2003). Recent tax changes may assist treatment of obesity.. PubMed. 16(1). 47–51, 55. 3 indexed citations
19.
Fitzner, Karen, et al.. (2000). Health care in Hong Kong and mainland China: one country, two systems?. Health Policy. 53(3). 147–155. 17 indexed citations
20.
Brown, Elizabeth D. & Karen Fitzner. (1999). Cost-effectiveness and coverage policy.. PubMed. 25(3). 75–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026